REFERENCES REVIEWED FOR 2007 GOLD UPDATE
Selected from PUB MED for the period July 1, 2006 through June 30, 2007
Criteria: COPD OR chronic bronchitis OR emphysema: All Fields - Limits: All Adult: 19+
years, abstracts, Clinical Trial, Human and
COPD OR chronic bronchitis OR emphysema AND systematic: All Fields - Limits:
abstracts, human.
1.
Aaron SD, Vandemheen KL, Fergusson D, et al. Tiotropium in combination with
placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary
disease: a randomized trial. Ann Intern Med 2007;146:545-55.
2.
Abreu Gonzalez J, Hernandez Garcia C, Abreu Gonzalez P, Martin Garcia C, Jimenez A.
[Effect of intravenous magnesium sulfate on chronic obstructive pulmonary disease
exacerbations requiring hospitalization: a randomized placebo-controlled trial]. Arch
Bronconeumol 2006;42:384-7.
3.
Adams SG, Anzueto A, Briggs DD, Jr., Menjoge SS, Kesten S. Tiotropium in COPD
patients not previously receiving maintenance respiratory medications. Respir Med
2006;100:1495-503.
4.
Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of
the chronic care model in chronic obstructive pulmonary disease prevention and management.
Arch Intern Med 2007;167:551-61.
5.
Antonaglia V, Lucangelo U, Zin WA, et al. Intrapulmonary percussive ventilation
improves the outcome of patients with acute exacerbation of chronic obstructive pulmonary
disease using a helmet. Crit Care Med 2006;34:2940-5.
6.
Antonelli-Incalzi R, Corsonello A, Trojano L, et al. Screening of cognitive impairment in
chronic obstructive pulmonary disease. Dement Geriatr Cogn Disord 2007;23:264-70.
7.
Armentia A, Bartolome B, Puyo M, et al. Tobacco as an allergen in bronchial disease.
Ann Allergy Asthma Immunol 2007;98:329-36.
8.
Arnardottir RH, Emtner M, Hedenstrom H, Larsson K, Boman G. Peak exercise capacity
estimated from incremental shuttle walking test in patients with COPD: a methodological study.
Respir Res 2006;7:127.
9.
Azarpazhooh A, Leake JL. Systematic review of the association between respiratory
diseases and oral health. J Periodontol 2006;77:1465-82.
10.
Balser E, Neher JO, Safranek S, Taraday J. Clinical inquiries: When are antibiotics
indicated for acute COPD exacerbations? J Fam Pract 2006;55:1079-80.
11.
Banasiak W, Pociupany R, Wilkins A, Ponikowski P. Characteristics of patients with
coronary artery disease managed on an outpatient basis in the population of Poland. Results of
the multicentre RECENT trial. Kardiol Pol 2007;65:132-40; discussion 41-2.
12.
Barr RG, Bourbeau J, Camargo CA, Ram FS. Tiotropium for stable chronic obstructive
pulmonary disease: A meta-analysis. Thorax 2006;61:854-62.
13.
Bathoorn E, Liesker J, Postma D, Koeter G, van Oosterhout AJ, Kerstjens HA. Safety of
sputum induction during exacerbations of COPD. Chest 2007;131:432-8.
14.
Battaglia E, Fulgenzi A, Bernucci S, Giardini ME, Ferrero ME. Home respiratory muscle
training in patients with chronic obstructive pulmonary disease. Respirology 2006;11:799-804.
15.
Bethke TD, Giessmann T, Westphal K, et al. Roflumilast, a once-daily oral
phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled
salbutamol when co-administered in healthy subjects. Int J Clin Pharmacol Ther 2006;44:572-9.
16.
Bourbeau J, Collet JP, Schwartzman K, Ducruet T, Nault D, Bradley C. Economic
benefits of self-management education in COPD. Chest 2006;130:1704-11.
17.
Butcher SJ, Pasiorowski MP, Jones RL. Effects of changes in lung volume on oscillatory
flow rate during high-frequency chest wall oscillation. Can Respir J 2007;14:153-8.
18.
Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and
survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89.
19.
Candy B, Taylor SJ, Ramsay J, Esmond G, Griffiths CJ, Bryar RM. Service implications
from a comparison of the evidence on the effectiveness and a survey of provision in England and
Wales of COPD specialist nurse services in the community. Int J Nurs Stud 2007;44:601-10.
20.
Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with
schizophrenia: a population-based controlled study. J Gen Intern Med 2006;21:1133-7.
21.
Casanova C, Cote CG, Marin JM, et al. The 6-min walking distance: long-term follow up
in patients with COPD. Eur Respir J 2007;29:535-40.
22.
Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalisations
for exacerbations in COPD patients. Eur Respir J 2006;28:123-30.
23.
Castagna O, Boussuges A, Vallier JM, Prefaut C, Brisswalter J. Is impairment similar
between arm and leg cranking exercise in COPD patients? Respir Med 2007;101:547-53.
24.
Cazzola M, Gabriella Matera M. The additive effect of theophylline on a combination of
formoterol and tiotropium in stable COPD: a pilot study. Respir Med 2007;101:957-62.
25.
Cazzola M, Mantero A, Santus P, et al. Doppler echocardiographic assessment of the
effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients.
Pulm Pharmacol Ther 2007;20:258-64.
26.
Christenhusz L, Pieterse M, Seydel E, van der Palen J. Prospective determinants of
smoking cessation in COPD patients within a high intensity or a brief counseling intervention.
Patient Educ Couns 2007;66:162-6.
27.
Colebourn CL, Barber V, Young JD. Use of helium-oxygen mixture in adult patients
presenting with exacerbations of asthma and chronic obstructive pulmonary disease: a systematic
review. Anaesthesia 2007;62:34-42.
28.
Connolly MJ, Lowe D, Anstey K, Hosker HS, Pearson MG, Roberts CM. Admissions to
hospital with exacerbations of chronic obstructive pulmonary disease: Effect of age related
factors and service organisation. Thorax 2006;61:843-8.
29.
Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered
outcomes. Chest 2007;131:696-704.
30.
Cully JA, Graham DP, Stanley MA, et al. Quality of life in patients with chronic
obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics
2006;47:312-9.
31.
Davis AH, Carrieri-Kohlman V, Janson SL, Gold WM, Stulbarg MS. Effects of treatment
on two types of self-efficacy in people with chronic obstructive pulmonary disease. J Pain
Symptom Manage 2006;32:60-70.
32.
de Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary
disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J
Respir Crit Care Med 2007;175:32-9.
33.
Di Marco F, Verga M, Santus P, Morelli N, Cazzola M, Centanni S. Effect of formoterol,
tiotropium, and their combination in patients with acute exacerbation of chronic obstructive
pulmonary disease: a pilot study. Respir Med 2006;100:1925-32.
34.
Donohue JF, Parsey MV, Andrews C, et al. Evaluation of the efficacy and safety of
levalbuterol in subjects with COPD. Copd 2006;3:125-32.
35.
Engelen MP, Rutten EP, De Castro CL, Wouters EF, Schols AM, Deutz NE.
Supplementation of soy protein with branched-chain amino acids alters protein metabolism in
healthy elderly and even more in patients with chronic obstructive pulmonary disease. Am J Clin
Nutr 2007;85:431-9.
36.
Eves ND, Petersen SR, Haykowsky MJ, Wong EY, Jones RL. Helium-hyperoxia,
exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Am J Respir Crit
Care Med 2006;174:763-71.
37.
Fisher D, Baird J, Payne L, et al. Are infant size and growth related to burden of disease
in adulthood? A systematic review of literature. Int J Epidemiol 2006;35:1196-210.
38.
FitzGerald JM, Haddon JM, Bradly-Kennedy C, Kuramoto L, Ford GT. Resource use
study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on
health care resource use among COPD patients. Can Respir J 2007;14:145-52.
39.
Forli L, Moum T, Bjortuft O, Vatn M, Boe J. The influence of underweight and dietary
support on well-being in lung transplant candidates. Respir Med 2006;100:1239-46.
40.
Foster JM, Aucott L, van der Werf RH, et al. Higher patient perceived side effects related
to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis.
Respir Med 2006;100:1318-36.
41.
Fregonese L, van Veen HP, Sterk PJ, Stolk J. Ventilation inhomogeneity in alpha1antitrypsin-deficient emphysema. Eur Respir J 2006;28:323-9.
42.
Fried TR, Van Ness PH, Byers AL, Towle VR, O'Leary JR, Dubin JA. Changes in
preferences for life-sustaining treatment among older persons with advanced illness. J Gen Intern
Med 2007;22:495-501.
43.
Garre M, Garo B, Ansart S, Le Berre R. [Acute exacerbation of chronic obstructive
pulmonary disease and antibiotics: analysis of comparative trials]. Med Mal Infect 2006;36:6906.
44.
Garty M, Shotan A, Gottlieb S, et al. The management, early and one year outcome in
hospitalized patients with heart failure: a national Heart Failure Survey in Israel--HFSIS 2003.
Isr Med Assoc J 2007;9:227-33.
45.
Ghezzi F, Cromi A, Bergamini V, et al. Laparoscopic management of endometrial cancer
in nonobese and obese women: A consecutive series. J Minim Invasive Gynecol 2006;13:269-75.
46.
Gohl O, Linz H, Schonleben T, Otte B, Weineck J, Worth H. [Benefits of a multimodular
outpatient training program for patients with COPD]. Pneumologie 2006;60:529-36.
47.
Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long-term survival after
heart failure: a contemporary population-based perspective. Arch Intern Med 2007;167:490-6.
48.
Gorse GJ, O'Connor T Z, Young SL, et al. Impact of a winter respiratory virus season on
patients with COPD and association with influenza vaccination. Chest 2006;130:1109-16.
49.
Gotfried M, Busman TA, Norris S, Notario GF. Role for 5-day, once-daily extendedrelease clarithromycin in acute bacterial exacerbation of chronic bronchitis. Curr Med Res Opin
2007;23:459-66.
50.
Grossman RF, Ambrusz ME, Fisher AC, Khashab MM, Kahn JB. Levofloxacin 750 mg
QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment
of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill
patients. Clin Ther 2006;28:1175-80.
51.
Gudmundsson G, Gislason T, Lindberg E, et al. Mortality in COPD patients discharged
from hospital: the role of treatment and co-morbidity. Respir Res 2006;7:109.
52.
Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, In E. The role of nebulised
budesonide in the treatment of exacerbations of COPD. Eur Respir J 2007;29:660-7.
53.
Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of COPD: a systematic
review. Eur Respir J 2006;28:330-8.
54.
Gupta RB, Brooks D, Lacasse Y, Goldstein RS. Effect of rollator use on health-related
quality of life in individuals with COPD. Chest 2006;130:1089-95.
55.
Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden
of COPD: systematic review and meta-analysis. Eur Respir J 2006;28:523-32.
56.
Hermann R, Nassr N, Lahu G, et al. Steady-state pharmacokinetics of roflumilast and
roflumilast N-oxide in patients with mild and moderate liver cirrhosis. Clin Pharmacokinet
2007;46:403-16.
57.
Hernandez G, Fernandez R, Luzon E, Cuena R, Montejo JC. The early phase of the
minute ventilation recovery curve predicts extubation failure better than the minute ventilation
recovery time. Chest 2007;131:1315-22.
58.
Hernandez-Diaz S, Garcia Rodriguez LA. Nonsteroidal anti-inflammatory drugs and risk
of lung cancer. Int J Cancer 2007;120:1565-72.
59.
Hirano T, Yamagata T, Gohda M, et al. Inhibition of reactive nitrogen species production
in COPD airways: comparison of inhaled corticosteroid and oral theophylline. Thorax
2006;61:761-6.
60.
Hjalmarsen A. [Rehabilitation of patients with chronic obstructive lung disease]. Tidsskr
Nor Laegeforen 2007;127:609-12.
61.
Hoff J, Tjonna AE, Steinshamn S, Hoydal M, Richardson RS, Helgerud J. Maximal
strength training of the legs in COPD: a therapy for mechanical inefficiency. Med Sci Sports
Exerc 2007;39:220-6.
62.
Hozawa A, Billings JL, Shahar E, Ohira T, Rosamond WD, Folsom AR. Lung function
and ischemic stroke incidence: the Atherosclerosis Risk in Communities study. Chest
2006;130:1642-9.
63.
Husain S, Kahane S, Friedman MG, et al. Simkania negevensis in bronchoalveolar lavage
of lung transplant recipients: a possible association with acute rejection. Transplantation
2007;83:138-43.
64.
Jaakkola MS, Jaakkola JJ. Impact of smoke-free workplace legislation on exposures and
health: possibilities for prevention. Eur Respir J 2006;28:397-408.
65.
Janaudis-Ferreira T, Wadell K, Sundelin G, Lindstrom B. Thigh muscle strength and
endurance in patients with COPD compared with healthy controls. Respir Med 2006;100:1451-7.
66.
Jungblut S, Frickmann H, Klingler J, Muller U, Bargon J. [Improvement in expiratory
peak flow (PEF) of COPD patients due to "lung" sport for 12 months.]. Pneumologie
2007;61:83-5.
67.
Kahn JB, Khashab M, Ambruzs M. Study entry microbiology in patients with acute
bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity. Curr
Med Res Opin 2007;23:1-7.
68.
Kahn SR, Panju A, Geerts W, et al. Multicenter evaluation of the use of venous
thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res
2007;119:145-55.
69.
Kardas P. Comparison of patient compliance with once-daily and twice-daily antibiotic
regimens in respiratory tract infections: results of a randomized trial. J Antimicrob Chemother
2007;59:531-6.
70.
Kardas P. Comparison of patient compliance with once-daily and twice-daily antibiotic
regimens in respiratory tract infections: results of a randomized trial. J Antimicrob Chemother
2007;59:531-6.
71.
Kardos P, Wencker M, Glaab T, Vogelmeier C. Impact of salmeterol/fluticasone
propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 2007;175:144-9.
72.
Kessler R, Stahl E, Vogelmeier C, et al. Patient understanding, detection, and experience
of COPD exacerbations: an observational, interview-based study. Chest 2006;130:133-42.
73.
Lederer DJ, Thomashow BM, Ginsburg ME, et al. Lung-volume reduction surgery for
pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and
exercise capacity index after 1 year. J Thorac Cardiovasc Surg 2007;133:1434-8.
74.
Lee P, Colt HG. A spray catheter technique for pleural anesthesia: a novel method for
pain control before talc poudrage. Anesth Analg 2007;104:198-200.
75.
Lesman-Leegte I, Jaarsma T, Sanderman R, Linssen G, van Veldhuisen DJ. Depressive
symptoms are prominent among elderly hospitalised heart failure patients. Eur J Heart Fail
2006;8:634-40.
76.
Lindholt JS. Relatively high pulmonary and cardiovascular mortality rates in screeningdetected aneurysmal patients without previous hospital admissions. Eur J Vasc Endovasc Surg
2007;33:94-9.
77.
Llor C, Cots JM, Herreras A. [Bacterial etiology of chronic bronchitis exacerbations
treated by primary care physicians]. Arch Bronconeumol 2006;42:388-93.
78.
Lopez Encuentra A, Pozo Rodriguez F, Martin de Nicolas JL, Villena V, Sayas Catalan J.
[Bronchioloalveolar carcinoma in Spain: a rare and different form of lung cancer]. Arch
Bronconeumol 2006;42:399-403.
79.
Makino S, Adachi M, Ohta K, et al. A prospective survey on safety of sustained-release
theophylline in treatment of asthma and COPD. Allergol Int 2006;55:395-402.
80.
Martens JD, Winkens RA, van der Weijden T, de Bruyn D, Severens JL. Does a joint
development and dissemination of multidisciplinary guidelines improve prescribing behaviour: a
pre/post study with concurrent control group and a randomised trial. BMC Health Serv Res
2006;6:145.
81.
Matic I, Danic D, Majeric-Kogler V, Jurjevic M, Mirkovic I, Mrzljak Vucinic N. Chronic
obstructive pulmonary disease and weaning of difficult-to-wean patients from mechanical
ventilation: randomized prospective study. Croat Med J 2007;48:51-8.
82.
Matthys H, Heger M. EPs 7630-solution--an effective therapeutic option in acute and
exacerbating bronchitis. Phytomedicine 2007;14 Suppl 6:65-8.
83.
McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of causespecific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax
2007;62:411-5.
84.
Miravitlles M, Llor C. Determining factors in the prescription of moxifloxacin in
exacerbations of chronic bronchitis in the primary-care setting. Clin Drug Investig 2007;27:95104.
85.
Mota S, Guell R, Barreiro E, et al. Clinical outcomes of expiratory muscle training in
severe COPD patients. Respir Med 2007;101:516-24.
86.
Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care
for adults in the United States as measured by adherence to recommended processes. Chest
2006;130:1844-50.
87.
Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of
hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006.
88.
Murray RP, Connett JE, Skeans MA, Tashkin DP. Menthol cigarettes and health risks in
Lung Health Study data. Nicotine Tob Res 2007;9:101-7.
89.
Naess O, Nafstad P, Aamodt G, Claussen B, Rosland P. Relation between concentration
of air pollution and cause-specific mortality: four-year exposures to nitrogen dioxide and
particulate matter pollutants in 470 neighborhoods in Oslo, Norway. Am J Epidemiol
2007;165:435-43.
90.
Nathan JA, Pearce L, Field C, et al. A randomized controlled trial of follow-up of
patients discharged from the hospital following acute asthma: best performed by specialist nurse
or doctor? Chest 2006;130:51-7.
91.
Naunheim KS, Wood DE, Mohsenifar Z, et al. Long-term follow-up of patients receiving
lung-volume-reduction surgery versus medical therapy for severe emphysema by the National
Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006;82:431-43.
92.
Nava S, Barbarito N, Piaggi G, De Mattia E, Cirio S. Physiological response to
intrapulmonary percussive ventilation in stable COPD patients. Respir Med 2006;100:1526-33.
93.
Navalesi P, Costa R, Ceriana P, et al. Non-invasive ventilation in chronic obstructive
pulmonary disease patients: helmet versus facial mask. Intensive Care Med 2007;33:74-81.
94.
Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic
obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden,
functional status, and quality of life. Arch Intern Med 2007;167:60-7.
95.
Nissen I, Jensen MS. [Nurse-supported discharge of patients with exacerbation of chronic
obstructive pulmonary disease]. Ugeskr Laeger 2007;169:2220-3.
96.
Oba Y. Cost-effectiveness of long-acting bronchodilators for chronic obstructive
pulmonary disease. Mayo Clin Proc 2007;82:575-82.
97.
Odencrants S, Ehnfors M, Grobe SJ. Living with chronic obstructive pulmonary disease
(COPD): part II. RNs' experience of nursing care for patients with COPD and impaired
nutritional status. Scand J Caring Sci 2007;21:56-63.
98.
O'Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during highintensity, constant-work-rate exercise in COPD. J Appl Physiol 2006;101:1025-35.
99.
O'Donnell DE, Sciurba F, Celli B, et al. Effect of fluticasone propionate/salmeterol on
lung hyperinflation and exercise endurance in COPD. Chest 2006;130:647-56.
100. Okudan N, Gok M, Gokbel H, Suerdem M. Single dose of tiotropium improves the 6minute walk distance in chronic obstructive pulmonary disease. Lung 2006;184:201-4.
101. Onorati F, Cristodoro L, Bilotta M, et al. Intraaortic balloon pumping during cardioplegic
arrest preserves lung function in patients with chronic obstructive pulmonary disease. Ann
Thorac Surg 2006;82:35-43.
102. Ozalevli S, Ozden A, Itil O, Akkoclu A. Comparison of the Sit-to-Stand Test with 6 min
walk test in patients with chronic obstructive pulmonary disease. Respir Med 2007;101:286-93.
103. Patel BD, Loo WJ, Tasker AD, et al. Smoking related COPD and facial wrinkling: is
there a common susceptibility? Thorax 2006;61:568-671.
104. Paul J, Otvos T. Comparison of nasal cannulas and the OxyArm in patients requiring
chronic domiciliary oxygen therapy. Can Respir J 2006;13:421-6.
105. Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR. Pulmonary rehabilitation improves
depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil
2007;86:30-6.
106. Pepin V, Brodeur J, Lacasse Y, et al. Six-minute walking versus shuttle walking:
responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax
2007;62:291-8.
107. Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW. Additive benefits of tiotropium
in COPD patients treated with long-acting beta agonists and corticosteroids. Respirology
2006;11:598-602.
108. Peters MM, Webb KA, O'Donnell DE. Combined physiological effects of
bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD. Thorax 2006;61:55967.
109. Phillips WT, Benton MJ, Wagner CL, Riley C. The effect of single set resistance training
on strength and functional fitness in pulmonary rehabilitation patients. J Cardiopulm Rehabil
2006;26:330-7.
110. Pinsky PF, Freedman M, Kvale P, Oken M, Caporaso N, Gohagan J. Abnormalities on
chest radiograph reported in subjects in a cancer screening trial. Chest 2006;130:688-93.
111. Plocek MD, Kondylis LA, Duhan-Floyd N, Reilly JC, Geisler DP, Kondylis PD.
Hemorrhoidopexy staple line height predicts return to work. Dis Colon Rectum 2006;49:1905-9.
112. Price LC, Lowe D, Hosker HS, Anstey K, Pearson MG, Roberts CM. UK National
COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome
following admission for acute COPD exacerbation. Thorax 2006;61:837-42.
113. Puhan MA, Busching G, Schunemann HJ, VanOort E, Zaugg C, Frey M. Interval versus
continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial.
Ann Intern Med 2006;145:816-25.
114. Puhan MA, Vollenweider D, Latshang T, Steurer J, Steurer-Stey C. Exacerbations of
chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review.
Respir Res 2007;8:30.
115. Quantrill SJ, Lowe D, Hosker HS, Anstey K, Pearson MG, Michael Roberts C. Survey of
early discharge schemes from the 2003 UK National COPD Audit. Respir Med 2007;101:102631.
116. Querol-Ribelles JM, Molina J, Naberan K, Esteban E, Herreras A, Garcia-de-Lomas J.
Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and
susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care
setting. Int J Antimicrob Agents 2006;28:472-6.
117. Raghunath AS, Innes A, Norfolk L, et al. Difficulties in the interpretation of lung
function tests in the diagnosis of asthma and chronic obstructive pulmonary disease. J Asthma
2006;43:657-60.
118. Raghunath AS, Innes A, Norfolk L, et al. Difficulties in the interpretation of lung
function tests in the diagnosis of asthma and chronic obstructive pulmonary disease. J Asthma
2006;43:657-60.
119. Ramsey SD, Shroyer AL, Sullivan SD, Wood DE. Updated evaluation of the costeffectiveness of lung volume reduction surgery. Chest 2007;131:823-32.
120. Raskin J, Spiegler P, McCusker C, et al. The effect of pulmonary rehabilitation on
healthcare utilization in chronic obstructive pulmonary disease: The Northeast Pulmonary
Rehabilitation Consortium. J Cardiopulm Rehabil 2006;26:231-6.
121. Rave K, de la Pena A, Tibaldi FS, et al. AIR inhaled insulin in subjects with chronic
obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability.
Diabetes Care 2007;30:1777-82.
122. Reilly J, Washko G, Pinto-Plata V, et al. Biological lung volume reduction: a new
bronchoscopic therapy for advanced emphysema. Chest 2007;131:1108-13.
123. Rennard SI, Fogarty C, Kelsen S, et al. The safety and efficacy of infliximab in moderate
to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:926-34.
124. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary Rehabilitation: Joint
ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007;131:4S-42S.
125. Rivera-Fernandez R, Navarrete-Navarro P, Fernandez-Mondejar E, Rodriguez-Elvira M,
Guerrero-Lopez F, Vazquez-Mata G. Six-year mortality and quality of life in critically ill
patients with chronic obstructive pulmonary disease. Crit Care Med 2006;34:2317-24.
126. Roede BM, Bresser P, El Moussaoui R, et al. Three vs. 10 days of amoxycillin-clavulanic
acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised,
double-blind study. Clin Microbiol Infect 2007;13:284-90.
127. Rogausch A, Kochen MM, Meineke C, Hennig J. Association between the BclI
glucocorticoid receptor polymorphism and smoking in a sample of patients with obstructive
airway disease. Addict Biol 2007;12:93-9.
128. Roth MD, Connett JE, D'Armiento JM, et al. Feasibility of retinoids for the treatment of
emphysema study. Chest 2006;130:1334-45.
129. Ruiz-Gonzalez A, Gimenez A, Gomez-Arbones X, et al. Open-label, randomized
comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in
acute exacerbations of chronic obstructive pulmonary disease. Respirology 2007;12:117-21.
130. Rutschmann OT, Cornuz J, Poletti PA, et al. Should pulmonary embolism be suspected in
exacerbation of chronic obstructive pulmonary disease? Thorax 2007;62:121-5.
131. Rutschmann OT, Cornuz J, Poletti PA, et al. Should pulmonary embolism be suspected in
exacerbation of chronic obstructive pulmonary disease? Thorax 2007;62:121-5.
132. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does
quality of life of COPD patients as measured by the generic EuroQol five-dimension
questionnaire differentiate between COPD severity stages? Chest 2006;130:1117-28.
133. Rysz J, Stolarek RA, Luczynski R, et al. Increased hydrogen peroxide concentration in
the exhaled breath condensate of stable COPD patients after nebulized N-acetylcysteine. Pulm
Pharmacol Ther 2007;20:281-9.
134. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on
post-myocardial infarction outcomes. Am J Cardiol 2007;99:636-41.
135. Salpeter SR, Buckley NS. Systematic review of clinical outcomes in chronic obstructive
pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids.
Clin Rev Allergy Immunol 2006;31:219-30.
136. Santiveri C, Espinalt M, Diaz Carrasco FX, Marin A, Miguel E, Jones PW. Evaluation of
male COPD patients' health status by proxies. Respir Med 2007;101:439-45.
137. Santos M, Braga JU, Gomes RV, Werneck GL. Predictive factors for pneumonia onset
after cardiac surgery in Rio de Janeiro, Brazil. Infect Control Hosp Epidemiol 2007;28:382-8.
138. Santus P, Centanni S, Verga M, Di Marco F, Matera MG, Cazzola M. Comparison of the
acute effect of tiotropium versus a combination therapy with single inhaler
budesonide/formoterol on the degree of resting pulmonary hyperinflation. Respir Med
2006;100:1277-81.
139. Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P. Lower inhaled steroid
requirement with a fluticasone/salmeterol combination in family practice patients with asthma or
COPD. Fam Pract 2007;24:181-8.
140. Schermer TR, Saris CG, van den Bosch WJ, et al. Exacerbations and associated
healthcare cost in patients with COPD in general practice. Monaldi Arch Chest Dis 2006;65:13340.
141. Schouten JA, Hulscher ME, Trap-Liefers J, et al. Tailored interventions to improve
antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled
trial. Clin Infect Dis 2007;44:931-41.
142. Schultz K, Bergmann KC, Kenn K, et al. [Effectiveness of inpatient pulmonary
rehabilitation (AHB). Results of a multicenter prospective observation study]. Dtsch Med
Wochenschr 2006;131:1793-8.
143. Sestini P, Cappiello V, Aliani M, et al. Prescription bias and factors associated with
improper use of inhalers. J Aerosol Med 2006;19:127-36.
144. Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. How long should outpatient
pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks. Thorax
2006;61:767-71.
145. Sheth K, Wasserman RL, Lincourt WR, Locantore NW, Carranza-Rosenzweig J, Crim C.
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated
dose counter: Performance and patient satisfaction. Int J Clin Pract 2006;60:1218-24.
146. Sichletidis L, Chloros D, Spyratos D, et al. The validity of the diagnosis of chronic
obstructive pulmonary disease in general practice. Prim Care Respir J 2007;16:82-8.
147. Sinha S, Goldstein M, Penrod J, et al. Brief report: beta-blocker use among veterans with
systolic heart failure. J Gen Intern Med 2006;21:1306-9.
148. Skogstad M, Kjaerheim K, Fladseth G, et al. Cross shift changes in lung function among
bar and restaurant workers before and after implementation of a smoking ban. Occup Environ
Med 2006;63:482-7.
149. Skumlien S, Skogedal EA, Bjortuft O, Ryg MS. Four weeks' intensive rehabilitation
generates significant health effects in COPD patients. Chron Respir Dis 2007;4:5-13.
150. Snow WM, Connett JE, Sharma S, Murray RP. Predictors of attendance and dropout at
the Lung Health Study 11-year follow-up. Contemp Clin Trials 2007;28:25-32.
151. Soler M, Mutterlein R, Cozma G. Double-blind study of OM-85 in patients with chronic
bronchitis or mild chronic obstructive pulmonary disease. Respiration 2007;74:26-32.
152. Starobin D, Kramer MR, Yarmolovsky A, et al. Assessment of functional capacity in
patients with chronic obstructive pulmonary disease: correlation between cardiopulmonary
exercise, 6 minute walk and 15 step exercise oximetry test. Isr Med Assoc J 2006;8:460-3.
153. Stein PD, Beemath A, Meyers FA, Olson RE. Pulmonary embolism and deep venous
thrombosis in hospitalized adults with chronic obstructive pulmonary disease. J Cardiovasc Med
(Hagerstown) 2007;8:253-7.
154. Stoller JK, Gildea TR, Ries AL, Meli YM, Karafa MT. Lung volume reduction surgery in
patients with emphysema and alpha-1 antitrypsin deficiency. Ann Thorac Surg 2007;83:241-51.
155. Stolz D, Pollak V, Chhajed PN, Gysin C, Pflimlin E, Tamm M. A randomized, placebocontrolled trial of bronchodilators for bronchoscopy in patients with COPD. Chest
2007;131:765-72.
156. Stratelis G, Molstad S, Jakobsson P, Zetterstrom O. The impact of repeated spirometry
and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care
2006;24:133-9.
157. Su CL, Chiang LL, Chiang TY, Yu CT, Kuo HP, Lin HC. Domiciliary positive
expiratory pressure improves pulmonary function and exercise capacity in patients with chronic
obstructive pulmonary disease. J Formos Med Assoc 2007;106:204-11.
158. Sunyer J, Jarvis D, Gotschi T, et al. Chronic bronchitis and urban air pollution in an
international study. Occup Environ Med 2006;63:836-43.
159. Tashkin DP, Klein GL, Colman SS, Zayed H, Schonfeld WH. Comparing COPD
treatment: nebulizer, metered dose inhaler, and concomitant therapy. Am J Med 2007;120:43541.
160. Ternesten-Hasseus E, Lowhagen O, Millqvist E. Quality of life and capsaicin sensitivity
in patients with airway symptoms induced by chemicals and scents: a longitudinal study. Environ
Health Perspect 2007;115:425-9.
161. Tinkelman DG, Price D, Nordyke RJ, Halbert RJ. COPD screening efforts in primary
care: what is the yield? Prim Care Respir J 2007;16:41-8.
162. Tonnesen P, Mikkelsen K, Bremann L. Nurse-conducted smoking cessation in patients
with COPD using nicotine sublingual tablets and behavioral support. Chest 2006;130:334-42.
163. Tsai CL, Clark S, Cydulka RK, Rowe BH, Camargo CA, Jr. Factors associated with
hospital admission among emergency department patients with chronic obstructive pulmonary
disease exacerbation. Acad Emerg Med 2007;14:6-14.
164. Tsai CL, Griswold SK, Clark S, Camargo CA, Jr. Factors associated with frequency of
emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen
Intern Med 2007;22:799-804.
165. Tsvetkova OA, Veselovskaia MV. [Efficacy of a cardioselective beta1-adrenoblocker
bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic
heart disease]. Ter Arkh 2007;79:25-9.
166. Urueta-Robledo J, Ariza H, Jardim JR, et al. Moxifloxacin versus levofloxacin against
acute exacerbations of chronic bronchitis: the Latin American Cohort. Respir Med
2006;100:1504-11.
167. Van Der Palen J, Eijsvogel MM, Kuipers BF, Schipper M, Vermue NA. Comparison of
the Diskus inhaler and the Handihaler regarding preference and ease of use. J Aerosol Med
2007;20:38-44.
168. van Helvoort HA, Heijdra YF, de Boer RC, Swinkels A, Thijs HM, Dekhuijzen PN. Sixminute walking-induced systemic inflammation and oxidative stress in muscle-wasted COPD
patients. Chest 2007;131:439-45.
169. van Veen IH, ten Brinke A, van der Linden AC, Rabe KF, Bel EH. Deficient alpha-1antitrypsin phenotypes and persistent airflow limitation in severe asthma. Respir Med
2006;100:1534-9.
170. van Zanten AR, Oudijk M, Nohlmans-Paulssen MK, van der Meer YG, Girbes AR,
Polderman KH. Continuous vs. intermittent cefotaxime administration in patients with chronic
obstructive pulmonary disease and respiratory tract infections:
pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy. Br J Clin
Pharmacol 2007;63:100-9.
171. Velloso M, Jardim JR. Study of energy expenditure during activities of daily living using
and not using body position recommended by energy conservation techniques in patients with
COPD. Chest 2006;130:126-32.
172. Verges S, Schulz C, Perret C, Spengler CM. Impaired abdominal muscle contractility
after high-intensity exhaustive exercise assessed by magnetic stimulation. Muscle Nerve
2006;34:423-30.
173. Vermeeren MA, Creutzberg EC, Schols AM, et al. Prevalence of nutritional depletion in
a large out-patient population of patients with COPD. Respir Med 2006;100:1349-55.
174. Virani S, Michaelson JS, Hutter MM, et al. Morbidity and mortality after liver resection:
results of the patient safety in surgery study. J Am Coll Surg 2007;204:1284-92.
175. Wagner PD. Skeletal muscles in chronic obstructive pulmonary disease: deconditioning,
or myopathy? Respirology 2006;11:681-6.
176. Wang Y, O'Donnell CA, Mackay DF, Watt GC. Practice size and quality attainment
under the new GMS contract: a cross-sectional analysis. Br J Gen Pract 2006;56:830-5.
177. Wasserman RL, Sheth K, Lincourt WR, Locantore NW, Rosenzweig JC, Crim C. Realworld assessment of a metered-dose inhaler with integrated dose counter. Allergy Asthma Proc
2006;27:486-92.
178. Watson L, Schouten JP, Lofdahl CG, Pride NB, Laitinen LA, Postma DS. Predictors of
COPD symptoms: does the sex of the patient matter? Eur Respir J 2006;28:311-8.
179. Wenisch C, Krause R, Szell M, Laferl H. Moxifloxacin versus standard therapy in
patients with pneumonia hospitalized after failure of preclinical anti-infective treatment.
Infection 2006;34:190-5.
180. Whale CI, Sovani MP, Mortimer K, et al. Effects of rac-albuterol on arterial blood gases
in patients with stable hypercapnic chronic obstructive pulmonary disease. Br J Clin Pharmacol
2006;62:153-7.
181. Wood DE, McKenna RJ, Jr., Yusen RD, et al. A multicenter trial of an intrabronchial
valve for treatment of severe emphysema. J Thorac Cardiovasc Surg 2007;133:65-73.
182. Wood-Baker R, McGlone S, Venn A, Walters EH. Written action plans in chronic
obstructive pulmonary disease increase appropriate treatment for acute exacerbations.
Respirology 2006;11:619-26.
183. Wood-Baker R, Walters J, Walters EH. Systemic corticosteroids in chronic obstructive
pulmonary disease: an overview of Cochrane systematic reviews. Respir Med 2007;101:371-7.
184. Wu HS, Lin LC, Wu SC, Lin JG. The psychologic consequences of chronic dyspnea in
chronic pulmonary obstruction disease: the effects of acupressure on depression. J Altern
Complement Med 2007;13:253-61.
185. Yem JS, Turner MJ, Baker AB. Sources of error in partial rebreathing pulmonary blood
flow measurements in lungs with emphysema and pulmonary embolism. Br J Anaesth
2006;97:732-41.
186. Yokoe K, Satoh K, Yamamoto Y, et al. Usefulness of 99mTc-Technegas and 133Xe
dynamic SPECT in ventilatory impairment. Nucl Med Commun 2006;27:887-92.
187. Zarins CK, Crabtree T, Bloch DA, Arko FR, Ouriel K, White RA. Endovascular
aneurysm repair at 5 years: Does aneurysm diameter predict outcome? J Vasc Surg 2006;44:92029; discussion 9-31.
188. Zervos M, Martinez FJ, Amsden GW, Rothermel CD, Treadway G. Efficacy and safety
of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial
exacerbations of chronic bronchitis. Int J Antimicrob Agents 2007;29:56-61.
189. Zhou Y, Wang X, Zeng X, et al. Positive benefits of theophylline in a randomized,
double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in
the treatment of COPD for 1 year. Respirology 2006;11:603-10.